341
Views
2
CrossRef citations to date
0
Altmetric
Review

Risk Factors for Descemet Membrane Endothelial Keratoplasty Rejection: Current Perspectives- Systematic Review

ORCID Icon, , ORCID Icon & ORCID Icon
Pages 421-440 | Received 30 Nov 2022, Accepted 27 Jan 2023, Published online: 01 Feb 2023

References

  • Gupta N, Tandon R, Gupta SK, Sreenivas V, Vashist P. Burden of corneal blindness in India. Indian J Community Med. 2013;38(4):198–206. doi:10.4103/0970-0218.120153
  • Jamali H, Gholampour AR. Indications and surgical techniques for corneal transplantation at a tertiary referral center. J Ophthalmic Vis Res. 2019;14(2):125–130. doi:10.4103/jovr.jovr_92_18
  • Wong KH, Kam KW, Chen LJ, Young AL. Corneal blindness and current major treatment concern-graft scarcity. Int J Ophthalmol. 2017;10(7):1154–1162. doi:10.18240/ijo.2017.07.21
  • Singh R, Gupta N, Vanathi M, Tandon R. Corneal transplantation in the modern era. Indian J Med Res. 2019;150(1):7–22. doi:10.4103/ijmr.IJMR_141_19
  • Fernandez MM, Afshari NA. Endothelial Keratoplasty: from DLEK to DMEK. Middle East Afr J Ophthalmol. 2010;17(1):5–8. doi:10.4103/0974-9233.61210
  • Trindade BLC, Eliazar GC. Descemet membrane endothelial keratoplasty (DMEK): an update on safety, efficacy and patient selection. Clin Ophthalmol. 2019;13:1549–1557. doi:10.2147/OPTH.S178473
  • Sugar J, Montoya M, Dontchev M, et al. Donor risk factors for graft failure in the cornea donor study. Cornea. 2009;28(9):981–985. doi:10.1097/ICO.0b013e3181a0a3e6
  • Gibbons A, Leung EH, Yoo SH. Cost-effectiveness analysis of descemet’s membrane endothelial keratoplasty versus descemet’s stripping endothelial keratoplasty in the United States. Ophthalmology. 2019;126(2):207–213. doi:10.1016/j.ophtha.2018.09.033
  • Phylactou M, Li JO, Larkin DFP. Characteristics of endothelial corneal transplant rejection following immunisation with SARS-CoV-2 messenger RNA vaccine. Br J Ophthalmol. 2021;105(7):893–896. doi:10.1136/bjophthalmol-2021-319338
  • Gurnani B, Czyz CN, Mahabadi N, Havens SJ. Corneal graft rejection. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.
  • Qazi Y, Hamrah P. Corneal allograft rejection: immunopathogenesis to therapeutics. J Clin Cell Immunol. 2013;2013(Suppl 9):006. doi:10.4172/2155-9899.S9-006
  • Beşek NK, Yalçınkaya G, Kırgız A, et al. Graft survival and clinical outcomes of Descemet membrane endothelial keratoplasty: long-term results. Int Ophthalmol. 2022;42(1):269–279. doi:10.1007/s10792-021-02078-4
  • Miyoshi Y, Ono T, Seki S, et al. Corneal graft rejection after descemet’s membrane endothelial keratoplasty with peripheral anterior synechiae. Case Rep Ophthalmol. 2022;13(1):17–22. doi:10.1159/000520877
  • Gómez-Benlloch A, Montesel A, Pareja-Aricò L, et al. Causes of corneal transplant failure: a multicentric study. Acta Ophthalmol. 2021;99(6):e922–e928. doi:10.1111/aos.14708
  • Pavlovic I, Shajari M, Herrmann E, Schmack I, Lencova A, Kohnen T. Meta-analysis of postoperative outcome parameters comparing descemet membrane endothelial keratoplasty versus descemet stripping automated endothelial keratoplasty. Cornea. 2017;36(12):1445–1451. doi:10.1097/ICO.0000000000001384
  • Deng SX, Lee WB, Hammersmith KM, et al. Descemet membrane endothelial keratoplasty: safety and outcomes: a report by the American Academy of Ophthalmology. Ophthalmology. 2018;125(2):295–310. doi:10.1016/j.ophtha.2017.08.015
  • Birbal RS, Ni Dhubhghaill S, Bourgonje VJA, et al. Five-year graft survival and clinical outcomes of 500 consecutive cases after descemet membrane endothelial keratoplasty. Cornea. 2020;39(3):290–297. doi:10.1097/ICO.0000000000002120
  • Vasiliauskaitė I, Oellerich S, Ham L, et al. Descemet membrane endothelial keratoplasty: ten-year graft survival and clinical outcomes. Am J Ophthalmol. 2020;217:114–120. doi:10.1016/j.ajo.2020.04.005
  • Droutsas K, Alexopoulos P, Giachos I, Giallouros E, Sekundo W, Lazaridis A. Secondary DMEK following failed primary DMEK. Int Ophthalmol. 2021;41(10):3287–3293. doi:10.1007/s10792-021-01890-2
  • Cohen E, Mimouni M, Sorkin N, et al. Risk factors for repeat descemet membrane endothelial keratoplasty graft failure. Am J Ophthalmol. 2021;226:165–171. doi:10.1016/j.ajo.2021.01.004
  • Çakmak S, Kirgiz A, Yildirim Y, Taşkoparan S, Genç S, Ağca A. The effect of anterior segment parameters on surgical success of Descemet membrane endothelial keratoplasty: a prospective study. Int Ophthalmol. 2022. doi:10.1007/s10792-022-02416-0
  • Gundlach E, Pilger D, Dietrich-Ntoukas T, Joussen AM, Torun N, Maier AB. Impact of re-bubbling after descemet membrane endothelial keratoplasty on long-term results. Curr Eye Res. 2021;46(6):784–788. doi:10.1080/02713683.2020.1842459
  • Hayashi T, Schrittenlocher S, Siebelmann S, et al. Risk factors for endothelial cell loss after descemet membrane endothelial keratoplasty (DMEK). Sci Rep. 2020;10(1):11086. doi:10.1038/s41598-020-68023-0
  • Leon P, Parekh M, Nahum Y, et al. Factors associated with early graft detachment in primary descemet membrane endothelial keratoplasty. Am J Ophthalmol. 2018;187:117–124. doi:10.1016/j.ajo.2017.12.014
  • Shahnazaryan D, Hajjar Sese A, Hollick EJ. Endothelial cell loss after descemet’s membrane endothelial keratoplasty for fuchs’ endothelial dystrophy: DMEK compared to triple DMEK. Am J Ophthalmol. 2020;218:1–6. doi:10.1016/j.ajo.2020.05.003
  • Schrittenlocher S, Grass C, Dietlein T, et al. Graft survival of Descemet membrane endothelial keratoplasty (DMEK) in corneal endothelial decompensation after glaucoma surgery. Graefes Arch Clin Exp Ophthalmol. 2022;260(5):1573–1582. doi:10.1007/s00417-021-05506-4
  • Alshaker S, Mimouni M, Batawi H, et al. Four-year survival comparison of endothelial keratoplasty techniques in patients with previous glaucoma surgery. Cornea. 2021;40(10):1282–1289. doi:10.1097/ICO.0000000000002585
  • Sorkin N, Mimouni M, Kisilevsky E, et al. Four-year survival of descemet membrane endothelial keratoplasty in patients with previous glaucoma surgery. Am J Ophthalmol. 2020;218:7–16. doi:10.1016/j.ajo.2020.05.020
  • Boutin T, Sorkin N, Einan-Lifshitz A, et al. Descemet membrane endothelial keratoplasty in patients with prior glaucoma surgery. Eur J Ophthalmol. 2021;31(4):2121–2126. doi:10.1177/1120672120936178
  • Santaella G, Sorkin N, Mimouni M, et al. Outcomes of descemet membrane endothelial keratoplasty in aphakic and aniridic patients. Cornea. 2020;39(11):1389–1393. doi:10.1097/ICO.0000000000002387
  • Hos D, Schlereth S, Schrittenlocher S, et al. “Descemet membrane endothelial keratoplasty” (DMEK) bei Transplantatversagen nach perforierender Keratoplastik und in vaskularisierten Hochrisikoaugen [Descemet membrane endothelial keratoplasty (DMEK) for graft failure after penetrating keratoplasty and in vascularized high-risk eyes]. Ophthalmologe. 2021;118(6):536–543. doi:10.1007/s00347-021-01384-7
  • Stein-Streilein J, Streilein JW. Anterior chamber associated immune deviation (ACAID): regulation, biological relevance, and implications for therapy. Int Rev Immunol. 2002;21(2–3):123–152. doi:10.1080/08830180212066
  • Hos D, Matthaei M, Bock F, et al. Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional penetrating corneal transplantation. Prog Retin Eye Res. 2019;73:100768. doi:10.1016/j.preteyeres.2019.07.001
  • Hos D, Schaub F, Cursiefen C. Does anterior chamber-associated immune deviation (ACAID) play a role in posterior lamellar keratoplasty? Case report of a splenectomized patient. BMC Ophthalmol. 2019;19(1):100. doi:10.1186/s12886-019-1114-1
  • Lavy I, Verdijk RM, Bruinsma M, et al. Sex chromosome analysis of postmortem corneal endothelium after sex-mismatch descemet membrane endothelial keratoplasty. Cornea. 2017;36(1):11–16. doi:10.1097/ICO.0000000000001019
  • Price MO, Price FW Jr. Descemet’s membrane endothelial keratoplasty surgery: update on the evidence and hurdles to acceptance. Curr Opin Ophthalmol. 2013;24(4):329–335. doi:10.1097/ICU.0b013e32836229ab
  • Marques RE, Guerra PS, Sousa DC, Gonçalves AI, Quintas AM, Rodrigues W. DMEK versus DSAEK for Fuchs’ endothelial dystrophy: a meta-analysis. Eur J Ophthalmol. 2019;29(1):15–22. doi:10.1177/1120672118757431
  • Basak SK, Basak S, Gajendragadkar N. Outcomes of descemet membrane endothelial keratoplasty using cornea from elderly donors aged 80 years and older: in the aftermath of current donor shortage. Cornea. 2021;41:1437–1443. doi:10.1097/ICO.0000000000002902
  • Price MO, Jordan CS, Moore G, Price FW Jr. Graft rejection episodes after Descemet stripping with endothelial keratoplasty: part two: the statistical analysis of probability and risk factors. Br J Ophthalmol. 2009;93(3):391–395. doi:10.1136/bjo.2008.140038
  • Price DA, Kelley M, Price FW Jr, Price MO. Five-year graft survival of descemet membrane Endothelial Keratoplasty (EK) versus descemet stripping EK and the effect of donor sex matching. Ophthalmology. 2018;125(10):1508–1514. doi:10.1016/j.ophtha.2018.03.050
  • Moshirfar M, Thomson AC, Ronquillo Y. Corneal endothelial transplantation. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.
  • Anshu A, Price MO, Richardson MR, et al. Alterations in the aqueous humor proteome in patients with a glaucoma shunt device. Mol Vis. 2011;17:1891–1900.
  • Carreras-Castañer X, Batlle-Ferrando S, Marin-Martinez S, Miguel L, Feu-Basilio S, Peraza-Nieves JE. Anterior synechiae related to an incipient Descemet’s membrane endothelial keratoplasty (DMEK) allograft rejection. J Fr Ophtalmol. 2020;43(10):e389–e391. doi:10.1016/j.jfo.2020.01.033
  • Price MO, Scanameo A, Feng MT, Price FW Jr. Descemet’s membrane endothelial keratoplasty: risk of immunologic rejection episodes after discontinuing topical corticosteroids. Ophthalmology. 2016;123(6):1232–1236. doi:10.1016/j.ophtha.2016.02.001
  • Shetty R, D’Souza S, Lalgudi VG. What ophthalmologists should know about conjunctivitis in the COVID-19 pandemic? Indian J Ophthalmol. 2020;68(5):683–687. doi:10.4103/ijo.IJO_869_20
  • Forshaw TRJ, Jørgensen C, Kyhn MC, Cabrerizo J. Acute bilateral descemet membrane endothelial keratoplasty graft rejection after the BNT162b2 mRNA COVID-19 vaccine. Int Med Case Rep J. 2022;15:201–204. doi:10.2147/IMCRJ.S362698
  • Bitton K, Dubois M, Courtin R, Panthier C, Gatinel D. Descemet’s membrane endothelial keratoplasty (DMEK) rejection following COVID-19 infection: a case report. Am J Ophthalmol Case Rep. 2021;23:101138. doi:10.1016/j.ajoc.2021.101138
  • Moriyama AS, Campos MSQ. Presumed DMEK graft rejection associated with COVID-19 infection. Cornea. 2022;41(2):e1. doi:10.1097/ICO.0000000000002882
  • Dapena I, Ham L, Netuková M, van der Wees J, Melles GR. Incidence of early allograft rejection after Descemet membrane endothelial keratoplasty. Cornea. 2011;30(12):1341–1345. doi:10.1097/ICO.0b013e31820d8540
  • Baydoun L, Livny E, Ham L, Bruinsma M, Melles GR. 360-degree scheimpflug imaging to predict allograft rejection after descemet membrane endothelial keratoplasty. Cornea. 2016;35(11):1385–1390. doi:10.1097/ICO.0000000000001007
  • Hos D, Tuac O, Schaub F, et al. Incidence and clinical course of immune reactions after descemet membrane endothelial keratoplasty: retrospective analysis of 1000 consecutive eyes. Ophthalmology. 2017;124(4):512–518. doi:10.1016/j.ophtha.2016.12.017
  • Schaub F, Bachmann BO, Cursiefen C, Hos D. Midterm follow-up of immune reactions after Descemet membrane endothelial keratoplasty (DMEK). Graefes Arch Clin Exp Ophthalmol. 2019;257(8):1811–1812. doi:10.1007/s00417-019-04357-4
  • Jordan CS, Price MO, Trespalacios R, Price FW Jr. Graft rejection episodes after Descemet stripping with endothelial keratoplasty: part one: clinical signs and symptoms. Br J Ophthalmol. 2009;93(3):387–390. doi:10.1136/bjo.2008.140020
  • Fu L, Hollick EJ. Long-term outcomes of descemet stripping endothelial keratoplasty: ten-year graft survival and endothelial cell loss. Am J Ophthalmol. 2022;234:215–222. doi:10.1016/j.ajo.2021.08.005
  • Moshirfar M. Recurrent endothelial rejection after DSAEK and DMEK causing corneal perforation in a patient with history of Fuchs endothelial dystrophy: October consultation #1. J Cataract Refract Surg. 2017;43(10):1358–1359. doi:10.1016/j.jcrs.2017.10.004
  • Monnereau C, Bruinsma M, Ham L, Baydoun L, Oellerich S, Melles GR. Endothelial cell changes as an indicator for upcoming allograft rejection following descemet membrane endothelial keratoplasty. Am J Ophthalmol. 2014;158(3):485–495. doi:10.1016/j.ajo.2014.05.030
  • Zygoura V, Baydoun L, Monnereau C, Satué M, Oellerich S, Melles GRJ. Dark endothelial spots after descemet membrane endothelial keratoplasty may appear as recurrent fuchs dystrophy or herald graft failure or rejection. Cornea. 2017;36(12):1480–1485. doi:10.1097/ICO.0000000000001375
  • Baydoun L, Bruinsma M, Santander-García D, Ham L, Oellerich S, Melles GRJ. Combined specular microscopy and Scheimpflug imaging to improve detection of an upcoming allograft rejection after DMEK. Acta Ophthalmol. 2020;98(3):261–266. doi:10.1111/aos.14234
  • Baydoun L, Chang Lam F, Schaal S, et al. Quantitative assessment of aqueous flare after descemet membrane endothelial keratoplasty for fuchs endothelial dystrophy. Cornea. 2018;37(7):848–853. doi:10.1097/ICO.0000000000001576
  • Okumura N, Velumani T, Hadiya F, et al. Analysis of immune cells on donor corneal endothelium after corneal transplantation using the HRT-Rostock cornea module. Cornea. 2021;40(11):1445–1452. doi:10.1097/ICO.0000000000002706
  • Muijzer MB, Hoven CMW, Frank LE, Vink G, Wisse RPL; Netherlands Corneal Transplant Network (NCTN). A machine learning approach to explore predictors of graft detachment following posterior lamellar keratoplasty: a nationwide registry study. Sci Rep. 2022;12(1):17705. doi:10.1038/s41598-022-22223-y
  • Hill JC, Maske R, Watson PG. The use of a single pulse of intravenous methylprednisolone in the treatment of corneal graft rejection. A preliminary report. Eye. 1991;5(Pt 4)):420–424. doi:10.1038/eye.1991.67
  • Nguyen NX, Seitz B, Martus P, Langenbucher A, Cursiefen C. Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty. Am J Ophthalmol. 2007;144(2):318–319. doi:10.1016/j.ajo.2007.03.028
  • Hill JC, Maske R, Watson P. Corticosteroids in corneal graft rejection. Oral versus single pulse therapy. Ophthalmology. 1991;98(3):329–333. doi:10.1016/S0161-6420(91)32291-7
  • Young AL, Rao SK, Cheng LL, Wong AK, Leung AT, Lam DS. Combined intravenous pulse methylprednisolone and oral cyclosporine A in the treatment of corneal graft rejection: 5-year experience. Eye. 2002;16(3):304–308. doi:10.1038/sj.eye.6700144
  • Azevedo Magalhaes O, Shalaby Bardan A, Zarei-Ghanavati M, Liu C. Literature review and suggested protocol for prevention and treatment of corneal graft rejection. Eye. 2020;34(3):442–450. doi:10.1038/s41433-019-0517-9
  • Price MO, Feng MT, Scanameo A, Price FW Jr. Loteprednol etabonate 0.5% gel vs. prednisolone acetate 1% solution after descemet membrane endothelial keratoplasty: prospective randomized trial. Cornea. 2015;34(8):853–858. doi:10.1097/ICO.0000000000000475
  • Price MO, Price FW Jr, Kruse FE, Bachmann BO, Tourtas T. Randomized comparison of topical prednisolone acetate 1% versus fluorometholone 0.1% in the first year after descemet membrane endothelial keratoplasty. Cornea. 2014;33(9):880–886. doi:10.1097/ICO.0000000000000206
  • Friehmann A, Myerscough J, Giannaccare G, Mazzoni M, Bovone C, Busin M. Successful descemet membrane endothelial keratoplasty in proven herpetic endothelial decompensation requires intensive antiviral therapy. Cornea. 2020;39(2):196–199. doi:10.1097/ICO.0000000000002215
  • Basak SK, Basak S. Descemet membrane endothelial keratoplasty in irreversible corneal edema due to herpes simplex virus endotheliitis. Cornea. 2020;39(1):8–12. doi:10.1097/ICO.0000000000002135
  • Tan TE, Tan DTH. Cytomegalovirus corneal endotheliitis after descemet membrane endothelial keratoplasty. Cornea. 2019;38(4):413–418. doi:10.1097/ICO.0000000000001847
  • Davidson M, Berkowitz E, Roberts H, Wanas A, Myerscough J. Selective laser trabeculoplasty for steroid-induced ocular hypertension following endothelial keratoplasty. Curr Eye Res. 2022;47(10):1362–1365. doi:10.1080/02713683.2022.2088800
  • Böhringer D, Schwartzkopff J, Maier PC, Reinhard T. Immunologie der keratoplastik: macht HLA-matching bei lamellären verfahren sinn? [HLA matching in keratoplasty: lessons learned from lamellar techniques]. Klin Monbl Augenheilkd. 2013;230(5):490–493. doi:10.1055/s-0032-1328256
  • Moura-Coelho N, Manero F, Elies D, et al. Repeat descemet membrane endothelial keratoplasty for failed primary descemet membrane endothelial keratoplasty at a referral center for keratoplasty in Spain: DIMOEK study. Am J Ophthalmol. 2020;215:49–55. doi:10.1016/j.ajo.2020.03.015
  • Wu J, Wu T, Li J, Wang L, Huang Y. DSAEK or DMEK for failed penetrating keratoplasty: a systematic review and single-arm meta-analysis. Int Ophthalmol. 2021;41(7):2315–2328. doi:10.1007/s10792-021-01778-1
  • Einan-Lifshitz A, Mednick Z, Belkin A, et al. Comparison of descemet stripping automated endothelial keratoplasty and descemet membrane endothelial keratoplasty in the treatment of failed penetrating keratoplasty. Cornea. 2019;38(9):1077–1082. doi:10.1097/ICO.0000000000001993
  • Baydoun L, van Dijk K, Dapena I, et al. Repeat Descemet membrane endothelial keratoplasty after complicated primary Descemet membrane endothelial keratoplasty. Ophthalmology. 2015;122(1):8–16. doi:10.1016/j.ophtha.2014.07.024
  • Agha B, Shajari M, Slavik-Lencova A, Kohnen T, Schmack I. Functional outcome of repeat Descemet membrane endothelial keratoplasty (DMEK) for corneal decompensation following graft failure after primary DMEK. Clin Ophthalmol. 2019;13:477–482. doi:10.2147/OPTH.S192424
  • Mimura T, Shimomura N, Usui T, et al. Magnetic attraction of iron-endocytosed corneal endothelial cells to Descemet’s membrane. Exp Eye Res. 2003;76(6):745–751. doi:10.1016/S0014-4835(03)00057-5
  • Nuzzi R, Marolo P, Tridico F. From DMEK to corneal endothelial cell therapy: technical and biological aspects. J Ophthalmol. 2018;2018:6482095. doi:10.1155/2018/6482095
  • Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13(12):4279–4295. doi:10.1091/mbc.e02-02-0105
  • Shah AP, Dzhaber D, Kenyon KR, Riaz KM, Ouano DP, Koo EH. Acute Corneal Transplant Rejection After COVID-19 Vaccination. Cornea. 2022;41(1):121–124. doi:10.1097/ICO.0000000000002878
  • Basak SK, Basak S, Gajendragadkar N, Ghatak M. Overall clinical outcomes of Descemet membrane endothelial keratoplasty in 600 consecutive eyes: a large retrospective case series. Indian J Ophthalmol. 2020;68(6):1044–1053. doi:10.4103/ijo.IJO_1563_19
  • Crnej A, Khoueir Z, Cherfan G, Saad A. Acute corneal endothelial graft rejection following COVID-19 vaccination. J Fr Ophtalmol. 2021;44(8):e445–e447. doi:10.1016/j.jfo.2021.06.001
  • Balidis M, Mikropoulos D, Gatzioufas Z, de Politis PB, Sidiropoulos G, Vassiliadis V. Acute corneal graft rejection after anti-severe acute respiratory syndrome-coronavirus-2 vaccination: a report of four cases. Eur J Ophthalmol. 2021;2021:11206721211064033.
  • Fu L, Hollick EJ. Rebubbling and graft detachment in Descemet membrane endothelial keratoplasty using a standardised protocol. Eye. 2022. doi:10.1038/s41433-022-02362-2
  • Maier AB, Pilger D, Gundlach E, Winterhalter S, Torun N, Dietrich-Ntoukas T. Graft failure rate and complications after Descemet membrane endothelial keratoplasty in eyes with pre-existing glaucoma. Graefes Arch Clin Exp Ophthalmol. 2022;30:1.
  • Jung YH, Yoon CH, Kim MK. Clinical outcome of Descemet membrane endothelial keratoplasty (DMEK) with imported donor corneas in eyes of Asian patients; endothelium-in versus endothelium-out method. PLoS One. 2022;17(6):e0270037. doi:10.1371/journal.pone.0270037
  • Sorkin N, Gouvea L, Din N, et al. Five-year safety and efficacy of femtosecond laser-assisted descemet membrane endothelial keratoplasty. Cornea. 2022. doi:10.1097/ICO.0000000000003019
  • Mittal V, Sehdev N, Mittal R. Descemet membrane endothelial keratoplasty in congenital hereditary endothelial dystrophy: initial experiences. Cornea. 2021;40(8):972–976. doi:10.1097/ICO.0000000000002701
  • Hayashi T, Zhang W, Hos D, et al. Descemet membrane endothelial keratoplasty in vascularized eyes: outcome and effect on corneal neovascularization. Cornea. 2021;40(6):685–689. doi:10.1097/ICO.0000000000002502
  • Mednick Z, Sorkin N, Einan-Lifshitz A, et al. Long-term outcomes of descemet membrane endothelial keratoplasty in post vitrectomized eyes with the use of pars plana infusion. Cornea. 2020;39(4):457–460. doi:10.1097/ICO.0000000000002228
  • Sorkin N, Mimouni M, Santaella G, et al. Comparison of manual and femtosecond laser-assisted descemet membrane endothelial keratoplasty for failed penetrating keratoplasty. Am J Ophthalmol. 2020;214:1–8. doi:10.1016/j.ajo.2019.11.015
  • Woo JH, Ang M, Htoon HM, Tan D. Descemet membrane endothelial keratoplasty versus descemet stripping automated endothelial keratoplasty and penetrating keratoplasty. Am J Ophthalmol. 2019;207:288–303. doi:10.1016/j.ajo.2019.06.012
  • Birbal RS, Tong CM, Dapena I, et al. Clinical outcomes of descemet membrane endothelial keratoplasty in eyes with a glaucoma drainage device. Am J Ophthalmol. 2019;199:150–158. doi:10.1016/j.ajo.2018.11.014
  • Showail M, Obthani MA, Sorkin N, et al. Outcomes of the first 250 eyes of Descemet membrane endothelial keratoplasty: Canadian centre experience. Can J Ophthalmol. 2018;53(5):510–517. doi:10.1016/j.jcjo.2017.11.017
  • Pasari A, Price MO, Feng MT, Price FW Jr. Descemet membrane endothelial keratoplasty for failed penetrating keratoplasty: visual outcomes and graft survival. Cornea. 2019;38(2):151–156. doi:10.1097/ICO.0000000000001763
  • Fajgenbaum MAP, Kopsachilis N, Hollick EJ. Descemet’s membrane endothelial keratoplasty: surgical outcomes and endothelial cell count modelling from a UK centre. Eye. 2018;32(10):1629–1635. doi:10.1038/s41433-018-0152-x
  • Weller JM, Kruse FE, Tourtas T. Descemet membrane endothelial keratoplasty: analysis of clinical outcomes of patients with 8–10 years follow-up. Int Ophthalmol. 2022;42(6):1789–1798. doi:10.1007/s10792-021-02176-3
  • Schrittenlocher S, Schaub F, Hos D, Siebelmann S, Cursiefen C, Bachmann B. Evolution of consecutive descemet membrane endothelial keratoplasty outcomes throughout a 5-year period performed by two experienced surgeons. Am J Ophthalmol. 2018;190:171–178. doi:10.1016/j.ajo.2018.03.036